VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SBCWWSBC Medical Group Holdings Incorporated
$0.32$33M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSBCWWBalance Sheet

SBC Medical Group Holdings Incorporated (SBCWW) Balance Sheet

4Y historyFree accessUpdated daily

SBCWW maintains a conservative capital structure, evidenced by a low 0.08 debt-to-equity ratio and a strong current ratio of 3.82 as of 2026Q1.

SBCWW Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22
Total Current Assets238.78M231.22M184.45M165.91M112.95M
Cash & Short-Term Investments167.31M164.09M125.04M103.02M53.64M
Cash Only167.31M163.77M125.04M103.02M51.74M
Short-Term Investments0319.19K001.91M
Accounts Receivable13.09M52.61M48.19M53.13M43.65M
Days Sales Outstanding120.03110.6285.63100.291.47
Inventory2.32M2.79M1.49M3.09M1.35M
Days Inventory Outstanding40.842211.0520.068.31
Other Current Assets56.06M11.72M25.54K162.12K37.23K
Total Non-Current Assets149.24M149.22M81.63M92.9M112.53M
Property, Plant & Equipment18.76M16.36M14.04M19.5M21.51M
Fixed Asset Turnover11.17x10.61x14.63x9.92x8.10x
Goodwill15.4M15.43M4.61M3.59M3.87M
Intangible Assets47.15M47.74M1.59M19.74M7.27M
Long-Term Investments128.06M58.02M20.87M20.66M916.03K
Other Non-Current Assets61.75M7.66M30.72M29.41M73.7M
Total Assets388.02M380.45M266.08M258.81M225.48M
Asset Turnover0.48x0.46x0.77x0.75x0.77x
Asset Growth %1602.49%42.98%2.81%14.78%-
Total Current Liabilities62.57M61.12M61.19M92.45M101.25M
Accounts Payable19.17M17.64M14.53M26.53M15.32M
Days Payables Outstanding140.21138.99107.46172.294.26
Short-Term Debt14.63M13.65M123.08K3.53M4.76M
Deferred Revenue (Current)29.31M9.47M12.56M25.13M30.44M
Other Current Liabilities27.76M11.54M227.89K832.52K25.2M
Current Ratio3.82x3.78x3.01x1.79x1.12x
Quick Ratio3.78x3.74x2.99x1.76x1.10x
Cash Conversion Cycle20.66-6.37-10.78-51.945.52
Total Non-Current Liabilities55.07M56.02M9.87M22.54M16.38M
Long-Term Debt5.83M33.73M6.51M13.01M5.53M
Capital Lease Obligations7.33M4.25M1.24M2.44M2.36M
Deferred Tax Liabilities40.71M16.37M926.02K6.01M7.34M
Other Non-Current Liabilities33.03M1.66M1.19M1.07M1.15M
Total Liabilities117.64M117.14M71.06M115M117.63M
Total Debt20.45M51.64M12.21M22.87M16.13M
Net Debt-146.85M-112.14M-112.83M-80.16M-35.61M
Debt / Equity0.08x0.20x0.06x0.16x0.15x
Debt / EBITDA0.32x0.74x0.16x0.28x0.62x
Net Debt / EBITDA-2.30x-1.60x-1.52x-0.97x-1.37x
Interest Coverage254.43x512.05x2596.61x1625.56x754.05x
Total Equity270.38M263.3M195.02M143.81M107.85M
Equity Growth %2196.03%35.01%35.61%33.34%-
Book Value per Share2.642.562.021.537.16
Total Shareholders' Equity255.34M248.28M195.11M142.16M105.25M
Common Stock10.39K10.39K10.3K9.42K0
Retained Earnings251.76M240.45M189.46M142.85M103.48M
Treasury Stock0-7.75M-2.7M00
Accumulated OCI-61.54M-57.29M-54.18M-37.58M-24.85M
Minority Interest15.04M15.02M-87K1.65M2.6M

Key Metrics

Growth RegimeContracting
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Geographic and Regulatory Concentration

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Expansion Amidst Contraction

According to recent financial statements, SBCWW's total assets have grown to $388.0M as of 2026Q1, yet this expansion appears decoupled from the underlying revenue decline, suggesting that the firm is accumulating capital rather than deploying it into high-growth operational assets to reverse the current top-line trend.

The divergence between rising asset levels and contracting revenue warrants investigation into whether the company is effectively utilizing its capital base. Investors should monitor if this asset accumulation is a strategic buffer for future M&A or a sign of diminishing returns on internal reinvestment.

Robust Liquidity Buffers Against Volatility

Based on reported figures, the company maintains a strong liquidity position with a current ratio of 3.82 in 2026Q1, supported by $167.3M in cash, which provides a substantial safety net against the operational volatility and revenue contraction observed in recent quarterly filings.

This high liquidity profile suggests the firm is well-positioned to navigate short-term economic headwinds or regulatory shifts in the Japanese market. However, the significant cash balance may also indicate a lack of immediate, high-return opportunities to deploy capital within the current franchise ecosystem.

Conservative Leverage Supports Financial Flexibility

As reported in recent filings, SBCWW maintains a conservative capital structure with a debt-to-equity ratio of 0.08 in 2026Q1, reflecting a strategic reliance on internal cash generation rather than external financing to fund its ongoing operations and infrastructure development across the franchisee network.

The minimal debt load suggests that the company is not currently exposed to significant interest rate risk or refinancing pressures. This low leverage profile appears to be a deliberate choice, potentially preserving the firm's ability to take on debt for future strategic initiatives if necessary.

Retained Earnings Drive Equity Growth

Based on the company's balance sheet data, equity has steadily increased to $255.3M by 2026Q1, primarily driven by the accumulation of $251.8M in retained earnings, which indicates that the firm has historically been successful in reinvesting profits back into the business to strengthen its net worth.

The consistent growth in retained earnings suggests a history of profitable operations, though the recent revenue contraction may challenge the sustainability of this trend. Analysts should evaluate whether future equity growth will continue to be supported by organic earnings or if external factors will necessitate a shift in capital allocation.

Hidden Risks in Asset Composition

As indicated by the latest quarterly data, the company's asset base includes $15.4M in goodwill, which warrants careful monitoring as it may represent potential impairment risk if the core franchise management model fails to maintain its competitive moat in the face of ongoing revenue declines.

While the current goodwill figure is relatively small, any significant deterioration in the performance of acquired assets or franchisee relationships could lead to non-cash write-downs. Investors should remain cautious about the quality of these intangible assets and their sensitivity to the broader Japanese aesthetic market environment.

SBCWW — Frequently Asked Questions

Quick answers to the most common questions about buying SBCWW stock.

What are the total assets of SBC Medical Group Holdings Incorporated (SBCWW)?

As of 2025, SBC Medical Group Holdings Incorporated (SBCWW) had total assets of $380.4M including $231.2M in current assets.

How much debt does SBC Medical Group Holdings Incorporated (SBCWW) have?

SBC Medical Group Holdings Incorporated (SBCWW) carries total debt of $51.6M, offset by $164.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of SBC Medical Group Holdings Incorporated?

SBC Medical Group Holdings Incorporated (SBCWW) has total shareholders' equity (book value) of $248.3M ($2.56 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is SBC Medical Group Holdings Incorporated's current ratio and liquidity?

SBC Medical Group Holdings Incorporated (SBCWW) reported a current ratio of 3.78x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.